Strategic Advisors
Webster K. Cavenee, Ph.D.
Pamela Garzone, Ph.D.
Chih-Kao Hu, Ph.D., MBA
Chih-Kao is an experienced management consultant working with top 100 pharmaceutical and biotech companies across more than 50 countries. His consulting approach concentrates in providing evidence-based commercialization strategies to healthcare…
Raju Kucherlapati, Ph.D.
Lou Lieto, Ph.D., J.D.
Dr. Louis D. Lieto is the leader of the patents and innovations department at Wilson Sonsini Goodrich & Rosati and is a partner in the firm’s Boston office. Lou advises…
Scott Lippman, M.D.
Scott M. Lippman, MD, is a Distinguished Professor of Medicine & Associate Vice Chancellor for Cancer Research at UC San Diego Health, professor of Medicine at UC San Diego School…
Jimmy Lu, J.D., MBA
Mr. Jimmy Lu has over 25+ years of high tech and venture capital experience. Having a background in technology investing, he focuses much of his time now on healthcare related…
Patty Obermaier
Program Advisors
Tonino Belmonte
Carlo M. Croce, M.D.
Dr. Croce entered the school of medicine of La Sapienza University of Rome and graduated in 1969 summa cum laude in medicine and Latin. He began his career in the…
Aleksandra Filipovic, M.D., Ph.D.
Aleksandra Filipovic MD, PhD, is head of oncology at PureTech, where she manages Oncology Asset Sourcing, review of oncology/ immuno oncology technologies and platforms from academia world-wide as well as…
Dimitra Georganopoulou, Ph.D.
Dimitra is an experienced biotech professional with deep knowledge of personalized medicine projects, therapeutics. medical devices, diagnostics, and Health IT. Dimitra is a general partner of Qral Ventures, and serves…
Jennifer Grandis, M.D.
Dr. Jennifer Grandis is an otolaryngologist and associate vice chancellor for clinical and translational research at UCSF. She directs the Clinical and Translational Science Institute, which provides resources and builds…
Beverly Lu, Ph.D.
Beverly Lu is a Biotech VC Investment Manager at Emerson Collective. Prior to joining Emerson, Beverly was a Director at Amgen, responsible for driving strategy and operations of the US…
Amy Millman
Gregory W. Mitchell, Ph.D., J.D.
Greg Mitchell is senior counsel at Wilson Sonsini Goodrich & Rosati. His expertise includes developing and implementing patent strategies, patent prosecution, and patent diligence (both buy and sell side) for…
Eifion Phillips, Ph.D., J.D.
Kanaga Sabapathy, Ph.D.
Michael Salgaller, Ph.D.
Dr. Michael Salgaller leads the Invention Development and Marketing Unit within the National Cancer Institute’s Technology Transfer Center, where he leverages over 20 years of business, scientific, and investment experience…
Paul Schimmel, Ph.D.
Fei Shen, Ph.D.
Fei is an Investment Director in the Boehringer Ingelheim Corporate Venture Fund. She joined the Boehringer Ingelheim Venture Fund in 2020 and is located in Boston, MA. Fei received her…
Thea Tlsty, Ph.D.
Dr. Thea Tlsty is Professor of Pathology at the University of California, San Francisco. She is known for her research in cancer biology, and her involvement in the discovery of…
Daniel D. Von Hoff M.D., F.A.C.P.
Barbara Weber, M.D.
Barbara is President and CEO of Tango Therapeutics, a biotechnology company she began building shortly after joining Third Rock Ventures (TRV) in March 2015. Tango launched with a $55M Series…